Ainhoa Lucia
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
In vitro characterization of GSK2556286 in combination with bedaquiline and pretomanid against Mycobacterium tuberculosis.
Journal: Antimicrobial agents and chemotherapy
Published: July 13, 2026
Use of hollow fiber systems to model treatment of infections: A practical guide.
Journal: iScience
Published: June 22, 2026
In vitro pharmacokinetics and pharmacodynamics of the diarylquinoline TBAJ-587 and its metabolites against Mycobacterium tuberculosis.
Journal: Frontiers in microbiology
Published: March 12, 2026
New Chemical Scaffold with Antimicrobial Activity Identified in a Screening of Industrial Photoactive Compounds.
Journal: Antibiotics (Basel, Switzerland)
Published: February 11, 2026
An assay toolkit for anti-tuberculosis drugs in the hollow fiber system.
Journal: iScience
Published: September 12, 2025
The emergence of resistance to the antiparasitic selamectin in Mycobacterium smegmatis is improbable and contingent on cell wall integrity.
Journal: Microbiology spectrum
Published: April 08, 2025
Protocol to quantify bacterial burden in time-kill assays using colony-forming units and most probable number readouts for Mycobacterium tuberculosis.
Journal: STAR protocols
Published: November 05, 2024
Citizen Science to Raise Antimicrobial Resistance Awareness in the Community: The MicroMundo Project in Spain and Portugal.
Journal: Microbial biotechnology
Published: November 01, 2024
Amoxicillin/clavulanate in combination with rifampicin/clarithromycin is bactericidal against Mycobacterium ulcerans.
Journal: PLoS neglected tropical diseases
Published: December 15, 2023
Evaluation of critical parameters in the hollow-fibre system for tuberculosis: A case study of moxifloxacin.
Journal: British journal of clinical pharmacology
Published: December 04, 2023
Implementing best practices on data generation and reporting of Mycobacterium tuberculosis in vitro assays within the ERA4TB consortium.
Journal: iScience
Published: July 04, 2022
Structure-aided optimization of non-nucleoside M. tuberculosis thymidylate kinase inhibitors.
Journal: European journal of medicinal chemistry
Published: April 30, 2021
Last Updated: 09/26/2026